Payment overview · 2025
General Payments
$163.71
7 reported records · 3 companies
Healthcare provider profile · identity verified
Oksana Levitansky, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROOKLYN, NY · NPI 1881623445
Verified facts
What the public records show
CMS Open Payments records show Oksana Levitansky, M.D. received $163.71 in general payments during 2025 across 7 reported records.
ABBVIE INC. accounted for 56.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Farxiga, Linzess.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 322 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 978 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported QULIPTA as an associated drug or biological on 298617 records involving 58957 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Qulipta by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 794 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported UBRELVY as an associated drug or biological on 299803 records involving 61203 distinct recipient NPIs. Public Medicare Part D data also shows 107 claims for Ubrelvy by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Vraylar by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NEXIUM as an associated drug or biological on 464 records involving 299 distinct recipient NPIs. Public Medicare Part D data also shows 226 claims for Nexium by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 76 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $92.30 | 56.4% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $46.41 | 28.4% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $25.00 | 15.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $163.71 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CREON Normalized: creon |
Drug | ABBVIE INC. | $92.30 | 4 | 2025 |
Source payment records
|
|||||
| CARDIOMEMS Normalized: cardiomems |
Device | Abbott Laboratories | $46.41 | 2 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $25.00 | 1 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $19.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 322 | exact normalized | Medicare Part D |
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 97 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 978 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
322 | 50 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
978 | 122 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | QULIPTA open payments reported associated product |
CMS Open Payments — General Payments 298617 supporting records · 58957 recipient NPIs · example record 1201352530 |
Qulipta · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
794 | 87 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | UBRELVY open payments reported associated product |
CMS Open Payments — General Payments 299803 supporting records · 61203 recipient NPIs · example record 1201352530 |
Ubrelvy · 2024 Exact normalized brand match · 1 Part D row |
107 | 16 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
97 | 13 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | NEXIUM open payments reported associated product |
CMS Open Payments — General Payments 464 supporting records · 299 recipient NPIs · example record 1206134180 |
Nexium · 2024 Exact normalized brand match · 1 Part D row |
226 | 33 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
76 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1473 | 191 |
| Diclofenac Sodium | Diclofenac Sodium | 1384 | 201 |
| Vascepa | Icosapent Ethyl | 1227 | 165 |
| Linzess | Linaclotide | 978 | 122 |
| Metoprolol Succinate | Metoprolol Succinate | 807 | 104 |
| Synthroid | Levothyroxine Sodium | 794 | 87 |
| Metformin Hcl | Metformin Hcl | 778 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 771 | 108 |
| Dexilant | Dexlansoprazole | 677 | 83 |
| Losartan Potassium | Losartan Potassium | 667 | 94 |
| Furosemide | Furosemide | 663 | 104 |
| Zenpep | Lipase/Protease/Amylase | 556 | 66 |
| Meloxicam | Meloxicam | 479 | 109 |
| Dexlansoprazole Dr | Dexlansoprazole | 470 | 68 |
| Mounjaro | Tirzepatide | 466 | 62 |
| Omeprazole | Omeprazole | 435 | 76 |
| Atorvastatin Calcium | Atorvastatin Calcium | 387 | 54 |
| Carvedilol | Carvedilol | 387 | 50 |
| Atenolol | Atenolol | 371 | 48 |
| Restasis | Cyclosporine | 371 | 47 |
| Famotidine | Famotidine | 361 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 356 | 61 |
| Meclizine Hcl | Meclizine Hcl | 344 | 66 |
| Gabapentin | Gabapentin | 331 | 63 |
| Creon | Lipase/Protease/Amylase | 322 | 50 |
| Lidocaine | Lidocaine | 322 | 47 |
| Livalo | Pitavastatin Calcium | 316 | 38 |
| Myrbetriq | Mirabegron | 306 | 38 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 297 | 38 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 296 | 35 |
| Ztlido | Lidocaine | 296 | 48 |
| Doxazosin Mesylate | Doxazosin Mesylate | 294 | 39 |
| Nebivolol Hcl | Nebivolol Hcl | 294 | 41 |
| Januvia | Sitagliptin Phosphate | 288 | 32 |
| Azithromycin | Azithromycin | 281 | 185 |
| Pantoprazole Sodium | Pantoprazole Sodium | 277 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 277 | 39 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 248 | 67 |
| Ammonium Lactate | Ammonium Lactate | 240 | 39 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 236 | 25 |
| Gralise | Gabapentin | 234 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 227 | 31 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 227 | 30 |
| Nexium | Esomeprazole Magnesium | 226 | 33 |
| Simvastatin | Simvastatin | 222 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 219 | 29 |
| Icosapent Ethyl | Icosapent Ethyl | 213 | 43 |
| Eliquis | Apixaban | 208 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 203 | 33 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 200 | 21 |
| Celecoxib | Celecoxib | 196 | 28 |
| Diclofenac Epolamine | Diclofenac Epolamine | 193 | 36 |
| Ozempic | Semaglutide | 191 | 29 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 184 | 48 |
| Lorazepam | Lorazepam | 183 | 54 |
| Jublia | Efinaconazole | 171 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 170 | 23 |
| Montelukast Sodium | Montelukast Sodium | 168 | 17 |
| Crestor | Rosuvastatin Calcium | 166 | 19 |
| Gemtesa | Vibegron | 165 | 22 |
| Ketoconazole | Ketoconazole | 163 | 29 |
| Clonazepam | Clonazepam | 161 | 27 |
| Benicar | Olmesartan Medoxomil | 157 | 16 |
| Bystolic | Nebivolol Hcl | 155 | 23 |
| Potassium Chloride | Potassium Chloride | 155 | 19 |
| Alprazolam | Alprazolam | 152 | 21 |
| Clotrimazole | Clotrimazole | 150 | 35 |
| Tradjenta | Linagliptin | 150 | 17 |
| Naproxen | Naproxen | 148 | 27 |
| Breo Ellipta | Fluticasone/Vilanterol | 145 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 144 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 144 | 15 |
| Repatha Sureclick | Evolocumab | 143 | 23 |
| Sucralfate | Sucralfate | 140 | 28 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 139 | 25 |
| Trulicity | Dulaglutide | 138 | 15 |
| Metformin Er Gastric | Metformin Hcl | 137 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 136 | 19 |
| Memantine Hcl Er | Memantine Hcl | 136 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 129 | 33 |
| Benicar Hct | Olmesartan/Hydrochlorothiazide | 127 | 13 |
| Entresto | Sacubitril/Valsartan | 125 | 19 |
| Tramadol Hcl | Tramadol Hcl | 125 | 33 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 122 | 18 |
| Valsartan | Valsartan | 120 | 16 |
| Advair Diskus | Fluticasone Propion/Salmeterol | 118 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 118 | 23 |
| Pitavastatin Calcium | Pitavastatin Calcium | 116 | 23 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 113 | 23 |
| Mupirocin | Mupirocin | 111 | 72 |
| Ibsrela | Tenapanor Hcl | 109 | 29 |
| Ubrelvy | Ubrogepant | 107 | 16 |
| Acyclovir | Acyclovir | 104 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 102 | 34 |
| Hydrocortisone | Hydrocortisone | 102 | 26 |
| Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | 101 | 13 |
| Trintellix | Vortioxetine Hydrobromide | 101 | 16 |
| Nitroglycerin | Nitroglycerin | 100 | 19 |
| Farxiga | Dapagliflozin Propanediol | 97 | 13 |
| Lactulose | Lactulose | 95 | 14 |
| Naftifine Hcl | Naftifine Hcl | 88 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 88 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 87 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 86 | 13 |
| Clonidine Hcl | Clonidine Hcl | 85 | 19 |
| Enalapril Maleate | Enalapril Maleate | 85 | suppressed |
| Procto-Med Hc | Hydrocortisone | 82 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 82 | 13 |
| Ranolazine Er | Ranolazine | 79 | 12 |
| Telmisartan | Telmisartan | 79 | suppressed |
| Xarelto | Rivaroxaban | 79 | suppressed |
| Eszopiclone | Eszopiclone | 78 | 13 |
| Nifedipine Er | Nifedipine | 78 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 77 | 12 |
| Edarbi | Azilsartan Medoxomil | 77 | 12 |
| Sertraline Hcl | Sertraline Hcl | 77 | suppressed |
| Cilostazol | Cilostazol | 76 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 76 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 76 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 76 | 11 |
| Ezetimibe | Ezetimibe | 75 | suppressed |
| Mupirocin | Mupirocin Calcium | 75 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 74 | suppressed |
| Fluconazole | Fluconazole | 72 | 45 |
| Proctozone-Hc | Hydrocortisone | 71 | 16 |
| Jardiance | Empagliflozin | 70 | 13 |
| Colchicine | Colchicine | 69 | 16 |
| Xiidra | Lifitegrast | 69 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | suppressed |
| Levothyroxine Sodium | Levothyroxine Sodium | 67 | 13 |
| Mometasone Furoate | Mometasone Furoate | 67 | 14 |
| Febuxostat | Febuxostat | 66 | 11 |
| Lansoprazole | Lansoprazole | 65 | suppressed |
| Memantine Hcl | Memantine Hcl | 64 | 14 |
| Mirtazapine | Mirtazapine | 64 | suppressed |
| Uloric | Febuxostat | 64 | suppressed |
| Levofloxacin | Levofloxacin | 61 | 45 |
| Loperamide | Loperamide Hcl | 61 | 13 |
| Repaglinide | Repaglinide | 61 | suppressed |
| Finasteride | Finasteride | 60 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 60 | suppressed |
| Toprol Xl | Metoprolol Succinate | 59 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 58 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 57 | 23 |
| Azelastine Hcl | Azelastine Hcl | 57 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 57 | suppressed |
| Nystatin | Nystatin | 57 | 14 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 57 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 57 | 14 |
| Single Use Swab | Alcohol Antiseptic Pads | 57 | 16 |
| Trazodone Hcl | Trazodone Hcl | 57 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 56 | suppressed |
| Allopurinol | Allopurinol | 55 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 53 | 17 |
| Pregabalin | Pregabalin | 52 | suppressed |
| Prolia | Denosumab | 52 | 31 |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 51 | 12 |
| Ramipril | Ramipril | 51 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 49 | suppressed |
| Glipizide | Glipizide | 48 | suppressed |
| Hydrocortisone Butyrate | Hydrocortisone Butyrate | 48 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 45 | suppressed |
| Rybelsus | Semaglutide | 45 | suppressed |
| Trulance | Plecanatide | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 43 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 42 | suppressed |
| Ibuprofen | Ibuprofen | 42 | 16 |
| Metformin Hcl Er | Metformin Hcl | 42 | suppressed |
| Metronidazole | Metronidazole | 42 | 12 |
| Ciclopirox | Ciclopirox | 41 | suppressed |
| Flector | Diclofenac Epolamine | 41 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 41 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | suppressed |
| Ssd | Silver Sulfadiazine | 40 | 12 |
| Baclofen | Baclofen | 38 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Nyamyc | Nystatin | 38 | suppressed |
| Ramelteon | Ramelteon | 38 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 37 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 37 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 36 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 36 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 36 | 34 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 35 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 35 | suppressed |
| Amcinonide | Amcinonide | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 34 | suppressed |
| Premarin | Estrogens, Conjugated | 34 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 34 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 33 | suppressed |
| Diovan | Valsartan | 32 | suppressed |
| Lunesta | Eszopiclone | 32 | suppressed |
| Torsemide | Torsemide | 32 | suppressed |
| Micardis | Telmisartan | 31 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 31 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 30 | suppressed |
| Mirabegron Er | Mirabegron | 30 | suppressed |
| Temazepam | Temazepam | 30 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 29 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 29 | suppressed |
| Endocet | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 29 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Oxiconazole Nitrate | Oxiconazole Nitrate | 28 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 28 | suppressed |
| Clemastine Fumarate | Clemastine Fumarate | 27 | suppressed |
| Dutasteride | Dutasteride | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 21 |
| Jentadueto | Linagliptin/Metformin Hcl | 26 | suppressed |
| Lotemax | Loteprednol Etabonate | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Oxycontin | Oxycodone Hcl | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Meloxicam | Meloxicam, Submicronized | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Fluocinolone Acetonide | Fluocinolone/Shower Cap | 24 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 24 | suppressed |
| Lisinopril | Lisinopril | 24 | suppressed |
| Mesalamine | Mesalamine | 24 | suppressed |
| Naproxen Sodium Er | Naproxen Sodium | 24 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 24 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 16 |
| Alcohol Pads | Alcohol Antiseptic Pads | 23 | suppressed |
| Aliskiren | Aliskiren Hemifumarate | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 23 | suppressed |
| Gabapentin Er | Gabapentin | 23 | 12 |
| Micardis Hct | Telmisartan/Hydrochlorothiazid | 23 | suppressed |
| Multaq | Dronedarone Hcl | 23 | suppressed |
| Vtama | Tapinarof | 23 | suppressed |
| Auvelity | Dextromethorphan Hbr/Bupropion | 22 | 12 |
| Bydureon Bcise | Exenatide Microspheres | 22 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 22 | suppressed |
| Novolin R | Insulin Regular, Human | 22 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 21 | suppressed |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 21 | 16 |
| Ibu | Ibuprofen | 21 | suppressed |
| Ursodiol | Ursodiol | 21 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 20 | suppressed |
| Latuda | Lurasidone Hcl | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 16 |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Methimazole | Methimazole | 19 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 19 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 19 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 18 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 18 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 11 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 17 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Cyclosporine | Cyclosporine | 17 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 17 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 17 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Vraylar | Cariprazine Hcl | 17 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 17 | suppressed |
| Ajovy Syringe | Fremanezumab-Vfrm | 16 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Letrozole | Letrozole | 16 | suppressed |
| Lipitor | Atorvastatin Calcium | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Silodosin | Silodosin | 16 | suppressed |
| Ambien Cr | Zolpidem Tartrate | 15 | suppressed |
| Budesonide Er | Budesonide | 15 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 15 | suppressed |
| Plavix | Clopidogrel Bisulfate | 15 | suppressed |
| Sure Comfort Alcohol | Alcohol Antiseptic Pads | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Butalbital-Acetaminophen | Butalbital/Acetaminophen | 14 | suppressed |
| Captopril | Captopril | 14 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Cozaar | Losartan Potassium | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Cyclobenzaprine Hcl Er | Cyclobenzaprine Hcl | 14 | suppressed |
| Exforge Hct | Amlodipine/Valsartan/Hcthiazid | 14 | suppressed |
| Fioricet | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Migranal | Dihydroergotamine Mesylate | 14 | suppressed |
| Misoprostol | Misoprostol | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Fluocinonide | Fluocinonide | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 13 | suppressed |
| Minoxidil | Minoxidil | 13 | suppressed |
| Norvasc | Amlodipine Besylate | 13 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 12 |
| Pimecrolimus | Pimecrolimus | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 13 | suppressed |
| Acetazolamide Er | Acetazolamide | 12 | suppressed |
| Aciphex | Rabeprazole Sodium | 12 | suppressed |
| Arthrotec 50 | Diclofenac Sodium/Misoprostol | 12 | suppressed |
| Emsam | Selegiline | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Ketoprofen | Ketoprofen | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Metaxalone | Metaxalone | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Motegrity | Prucalopride Succinate | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 12 | suppressed |
| Qulipta | Atogepant | 12 | suppressed |
| Rapaflo | Silodosin | 12 | suppressed |
| Xeljanz | Tofacitinib Citrate | 12 | suppressed |
| Ambien | Zolpidem Tartrate | 11 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Cimetidine | Cimetidine | 11 | suppressed |
| Dayvigo | Lemborexant | 11 | suppressed |
| Easy Touch | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Eplerenone | Eplerenone | 11 | suppressed |
| Frovatriptan Succinate | Frovatriptan Succinate | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Tribenzor | Olmesartan/Amlodipin/Hcthiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $163.71 · 7 records | ABBVIE INC. | CARDIOMEMS, CREON, FARXIGA, LINZESS | 11 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error